Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal potassium (K+) channels are a diverse group of ion channels expressed in the smooth muscle cells of the gastrointestinal (GI) tract that play a critical role in regulating motility [3, 5]. These channels include several subtypes, most notably the large-conductance calcium-activated (BK), small-conductance calcium-activated (SK), voltage-gated (Kv), and ATP-sensitive (KATP) potassium channels [3, 5]. Their primary biological function is to facilitate the efflux of K+ ions, which leads to membrane hyperpolarization and the subsequent closure of voltage-gated calcium channels [3, 5]. This process reduces intracellular calcium availability, thereby promoting smooth muscle relaxation and modulating GI motility [3, 5]. Dysregulation of these channels is implicated in various functional gastrointestinal disorders, such as irritable bowel syndrome (IBS), functional dyspepsia, and chronic intestinal pseudo-obstruction [3]. Pharmacological agents that act as K+ channel openers, such as pinacidil and diazoxide, are being explored as therapeutic options to treat conditions characterized by hypercontractility or spasms [3, 4]. Conversely, channel blockers like apamin or glibenclamide are used to study the underlying electrical activity of the gut or to treat conditions like secretory diarrhea [2, 3, 8]. Understanding the specific roles of these channel subtypes in different regions of the intestine is crucial for developing targeted therapies with minimal systemic side effects [3]. Natural compounds like quercetin and naringenin have also been shown to modulate these channels, contributing to their antispasmodic effects [4, 5]. Overall, these channels represent a significant therapeutic target for managing GI motility and related symptoms [3].
Activation of these channels increases the efflux of potassium ions, leading to membrane hyperpolarization. This hyperpolarization inhibits the opening of voltage-gated calcium channels, thereby reducing intracellular calcium levels and causing smooth muscle relaxation [3, 5].
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium channel (intestinal smooth muscle) (K+ channels).